Front Row Advisors’s First Trust Health Care AlphaDEX Fund FXH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-20
Closed -$2K 925
2023
Q2
$2K Hold
20
﹤0.01% 803
2023
Q1
$2K Hold
20
﹤0.01% 816
2022
Q4
$2K Hold
20
﹤0.01% 781
2022
Q3
$2K Hold
20
﹤0.01% 810
2022
Q2
$2K Hold
20
﹤0.01% 815
2022
Q1
$2K Hold
20
﹤0.01% 854
2021
Q4
$2K Hold
20
﹤0.01% 878
2021
Q3
$2K Hold
20
﹤0.01% 862
2021
Q2
$2K Hold
20
﹤0.01% 865
2021
Q1
$2K Hold
20
﹤0.01% 859
2020
Q4
$2K Hold
20
﹤0.01% 823
2020
Q3
$2K Buy
+20
New +$1.87K ﹤0.01% 822

Other funds holding FXH

Front Row Advisors's FXH Position: Q3 2023 in Review

Front Row Advisors sold out of First Trust Health Care AlphaDEX Fund (FXH) in Q3 2023, closing a stake of 20 shares — an estimated $2K sold.

Front Row Advisors first reported a position in FXH in Q3 2020 and held it in 12 quarters. The position peaked at $2K in Q2 2023. 249 funds tracked by Wall St. Rank hold FXH as of Q3 2023.

  • Front Row Advisors reported no remaining First Trust Health Care AlphaDEX Fund position as of Q3 2023 after selling out during the quarter.
  • Front Row Advisors sold 20 First Trust Health Care AlphaDEX Fund shares in Q3 2023, an estimated $2K.
  • Front Row Advisors first reported a position in First Trust Health Care AlphaDEX Fund in Q3 2020 and held it in 12 quarters.
  • Front Row Advisors's First Trust Health Care AlphaDEX Fund position peaked at $2K in Q2 2023.
  • 249 funds tracked by Wall St. Rank held First Trust Health Care AlphaDEX Fund as of Q3 2023.

Based on Front Row Advisors's 13F filing for Q3 2023, filed 15 Nov 2023.